These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 7947821

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R, Toth M, Peña D, Mobashery S.
    Cancer Res; 1995 Jun 15; 55(12):2548-55. PubMed ID: 7780967
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2.
    Olson MW, Gervasi DC, Mobashery S, Fridman R.
    J Biol Chem; 1997 Nov 21; 272(47):29975-83. PubMed ID: 9368077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH, Lottspeich F, Ries C, Petrides PE.
    Exp Hematol; 1995 Feb 21; 23(2):155-60. PubMed ID: 7828672
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
    Aimes RT, Quigley JP.
    J Biol Chem; 1995 Mar 17; 270(11):5872-6. PubMed ID: 7890717
    [Abstract] [Full Text] [Related]

  • 14. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K, Lohi J, Valtanen H, Keski-Oja J.
    Biochem J; 1998 Sep 01; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P.
    J Cell Biol; 1997 Apr 07; 137(1):67-77. PubMed ID: 9105037
    [Abstract] [Full Text] [Related]

  • 16. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec 07; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

  • 17. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
    Riley SC, Leask R, Chard T, Wathen NC, Calder AA, Howe DC.
    Mol Hum Reprod; 1999 Apr 07; 5(4):376-81. PubMed ID: 10321811
    [Abstract] [Full Text] [Related]

  • 18. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone.
    Rao VH, Bridge JA, Neff JR, Schaefer GB, Buehler BA, Vishwanatha JK, Pollock RE, Nicolson GL, Yamamoto M, Gokaslam ZL.
    Clin Exp Metastasis; 1995 Nov 07; 13(6):420-6. PubMed ID: 7586800
    [Abstract] [Full Text] [Related]

  • 19. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
    Allan JA, Docherty AJ, Murphy G.
    Ann N Y Acad Sci; 1994 Sep 06; 732():365-6. PubMed ID: 7978809
    [No Abstract] [Full Text] [Related]

  • 20. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T, Okada Y, Nakanuma Y.
    Hepatology; 1996 Jun 06; 23(6):1341-4. PubMed ID: 8675149
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.